Australia -
Kiingereza -
Department of Health (Therapeutic Goods Administration)
trulicity dulaglutide (rch) 1.5 mg/0.5 ml solution for injection prefilled syringe
eli lilly australia pty ltd - dulaglutide -
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
forxiga 5mg tablets
astrazeneca uk ltd - dapagliflozin propanediol monohydrate - tablet - 5mg
Uingereza -
Kiingereza -
MHRA (Medicines & Healthcare Products Regulatory Agency)
forxiga 10mg tablets
astrazeneca uk ltd - dapagliflozin propanediol monohydrate - tablet - 10mg
Nyuzilandi -
Kiingereza -
Medsafe (Medicines Safety Authority)
trulicity
eli lilly and company (nz) limited - dulaglutide 3 mg/ml - solution for injection - 1.5 mg/0.5ml - active: dulaglutide 3 mg/ml excipient: citric acid mannitol polysorbate 80 sodium citrate dihydrate water for injection - type 2 diabetes mellitus: glycaemic control: trulicity is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus: o as monotherapy. o in combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see section 5.1 for data with respect to different combinations). type 2 diabetes mellitus: reduction in risk of major adverse cardiovascular events: trulicity is indicated as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have: o established cardiovascular disease or o multiple cardiovascular risk factors
Kanada -
Kiingereza -
Health Canada
ozempic solution
novo nordisk canada inc - semaglutide - solution - 1mg - semaglutide 1mg - incretin mimetics
Kanada -
Kiingereza -
Health Canada
ozempic solution
novo nordisk canada inc - semaglutide - solution - 1.34mg - semaglutide 1.34mg - incretin mimetics
Kanada -
Kiingereza -
Health Canada
ozempic solution
novo nordisk canada inc - semaglutide - solution - 2.68mg - semaglutide 2.68mg
Kanada -
Kiingereza -
Health Canada
ozempic solution
novo nordisk canada inc - semaglutide - solution - 0.68mg - semaglutide 0.68mg
Malesia -
Kiingereza -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
ozempic® 1.34 mgml (1 mgdose) solution for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - semaglutide -
Malesia -
Kiingereza -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
ozempic® 1.34 mgml (0.25 mg 0.5 mgdose) solution for injection in pre-filled pen
novo nordisk pharma (malaysia) sdn. bhd. - semaglutide -